California Stem-Cell Case Winds Down

Saskal, Rich
March 2006
Bond Buyer;3/3/2006, Vol. 355 Issue 32331, p1
Trade Publication
The article reports on the case over the validity of California's plans to issue $3 billion in general obligation bonds to finance stem-cell medical research. Opponents of the medical stem-cell research argue that the voter-approved Proposition 71 violated the state constitution because it allowed taxpayer funds to be spent by the California Institute for Regenerative Medicine (CIRM). CIRM is the organization created by Proposition 71 to manage the stem-cell research program.


Related Articles

  • Stanford wins CIRM grants for stem cell research, worth $15M.  // Medical Device Daily;3/20/2007, Vol. 11 Issue 53, p5 

    This article reports that researchers at the Stanford University School of Medicine were awarded six grants worth more than $15 million from the California Institute for Regenerative Medicine (CIRM). The grants were given to experienced stem cell researchers continuing established programs. The...

  • Adult stem cell research surges ahead.  // Indianapolis Business Journal;8/16/2010, Vol. 31 Issue 24, p20 

    The article reports on the increasing interest of researchers to focus their endeavors on adult stem cell research.

  • Stern cell scientists call for open process for reviewing research. Mayor, Susan // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/13/2010, Vol. 340 Issue 7742, p335 

    The article focuses on the claim of stem cell researchers that reviewers might be hindering the publication of high quality research.

  • FROM THE EDITORS.  // APA Newsletters;Fall2008, Vol. 8 Issue 1, Special section p1 

    The article discusses various reports published within the issue including one about the conflict between scientific progress and political process and another on a proposed bill concerning the mediation of the social turmoil surrounding stem cell research.

  • The Vatican, University of Maryland enter into adult stem cell research partnership to study intestinal and other diseases.  // Transplant News;May2010, Vol. 20 Issue 5, p11 

    The article reports on the announcement of the Vatican and the University of Maryland School of Medicine regarding their partnership to study the use adult stem cells in the treatment of intestinal and other diseases.

  • CALIFORNIA: Stem Cell GOs Get Global Aaa. Saskal, Rich // Bond Buyer;9/21/2007, Vol. 361 Issue 32718, p9 

    The article reports that Moody's Investors Service Inc. has assigned its Aaa global scale rating to California's forthcoming general obligation (GO) bond sale for its stem cell medical research program on September 18, 2007. The report noted that the planned $250 million bond issue, expected to...

  • Politically Correct Human Embryonic Stem Cells? Solter, Davor // New England Journal of Medicine;12/1/2005, Vol. 353 Issue 22, p2321 

    The article focuses on two studies related to embryonic stem-cell lines. In one of the studies, mouse embryonic stem-cell lines were derived from single blastomeres of embryos at the eight-cell stage and transferred the remaining seven-cell embryos into surrogate mothers. In another study, a...

  • The Administration. Acomb, Deborah L. // National Journal;8/11/2001, Vol. 33 Issue 32, p2561 

    Reports the results of a survey which investigated the views of United States citizens on whether funding should be used in stem-cell research as of August 2001. Difference of the findings with a similar survey conducted in June, 2001.

  • Harnessed stem cells bring hope for infertile.  // Medical Ethics Advisor;Apr2012, Vol. 28 Issue 4, p45 

    The article presents a clinical research report led by Jonathan Tilly, professor at the MGH Vincent Department of Obstetrics and Gynecology, related to discovery of the ovaries of women harbor rare stem cells for treating infertile women.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics